Alcohol consumption and risk of lymphoid and myeloid neoplasms: Results of the Netherlands cohort study

Mirjam M. Heinen, Bas A. J. Verhage*, Leo J. Schouten, R. Alexandra Goldbohm, Harry C. Schouten, Piet A. van den Brandt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Web of Science)


Results from epidemiological studies suggest that alcohol drinkers have a decreased risk of lymphoid neoplasms, whereas results for myeloid neoplasms are inconsistent. However, most of these studies have used retrospective data. We examined prospectively whether alcohol consumption decreases the risk of both lymphoid and myeloid neoplasms, including most common subtypes. Moreover, we investigated whether this decreased risk is due to ethanol or other contents of specific alcoholic beverages (i.e., beer, wine and liquor). The Netherlands cohort study consisted of 120,852 individuals who completed a baseline questionnaire in 1986. After 17.3 years of follow-up, 1,375 cases of lymphoid and 245 cases of myeloid neoplasms with complete exposure information were available for analysis. Compared with abstinence, we observed for plasma cell neoplasms hazard rate ratios (HR) of 1.66 (95% confidence interval (CI), 1.21-2.29), 1.63 (95% CI, 1.17-2.27), 1.11 (95% CI, 0.75-1.64) and 0.85 (95% CI, 0.51-1.42) with daily ethanol consumption of 0.1-
Original languageEnglish
Pages (from-to)1701-1712
JournalInternational Journal of Cancer
Issue number7
Publication statusPublished - 1 Oct 2013


  • lymphoid neoplasms
  • myeloid neoplasms
  • alcoholic beverages
  • ethanol
  • cohort study

Cite this